Cargando…

Is PEGylated G-CSF superior to G-CSF in patients with breast cancer receiving chemotherapy? A systematic review and meta-analysis

BACKGROUND: PEGylated granulocyte colony-stimulating factor (G-CSF) is a safe alternative to G-CSF to improve chemotherapy-induced neutropenia (CIN). This superiority has resulted in its increased use by physicians; however, the superiority of PEGylated G-CSF for CIN in breast cancer has not been co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiang, Zheng, Huan, Yu, Man-Cheng, Wang, Wei, Wu, Xin-Hong, Yang, Dong-Mei, Xu, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333975/ https://www.ncbi.nlm.nih.gov/pubmed/32621264 http://dx.doi.org/10.1007/s00520-020-05603-w

Ejemplares similares

Pegylated G-CSF Combined with mFOLFIRINOX for Advanced Pancreatic Cancer Patients
por: Chen, Peng, et al.
Publicado: (2019)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF versus G-CSF alone
por: Sung, Anthony D., et al.
Publicado: (2013)

Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies
por: Bonanno, Giuseppina, et al.
Publicado: (2010)

Comparison of Therapeutic G-CSF Cycles and Prophylactic G-CSF Cycles in Patients Receiving Paclitaxel and Carboplatin Combination Chemotherapy for Ovarian Cancer: A Retrospective Study Report
por: Kawashima, Masaaki, et al.
Publicado: (2014)

Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients
por: Jiang, Yantao, et al.
Publicado: (2023)

Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function
por: Bakherad, Hamid, et al.
Publicado: (2020)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

Co-Therapy of Pegylated G-CSF and Ghrelin for Enhancing Survival After Exposure to Lethal Radiation
por: Kiang, Juliann G., et al.
Publicado: (2021)

Improving the Therapeutic Potential of G-CSF through Compact Circular PEGylation Based on Orthogonal Conjugations
por: Grigoletto, Antonella, et al.
Publicado: (2023)

Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children
por: Meraz, José Eugenio Vázquez, et al.
Publicado: (2016)

Regulation of the bone marrow microenvironment by G-CSF: Effects of G-CSF on acute lymphoblastic leukaemia
por: Basnett, Jordan, et al.
Publicado: (2017)

G-CSF drives autoinflammation in APLAID
por: Mulazzani, Elisabeth, et al.
Publicado: (2023)

Corrigendum to “Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children”
por: Vázquez Meraz, José Eugenio, et al.
Publicado: (2016)

Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF
por: Sun, Hong-Wei, et al.
Publicado: (2021)

Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis
por: Wang, Liwen, et al.
Publicado: (2021)

G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors
por: He, Kai, et al.
Publicado: (2022)

Model-based optimization of G-CSF treatment during cytotoxic chemotherapy
por: Schirm, Sibylle, et al.
Publicado: (2017)

Neutropenia and G-CSF in lymphoproliferative diseases
por: Ria, Roberto, et al.
Publicado: (2013)

Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice
por: Christopher, Matthew J., et al.
Publicado: (2011)

Role of ceramide synthase 2 in G-CSF signaling and G-CSF-R translocation into detergent-resistant membranes
por: Kurz, Jennifer, et al.
Publicado: (2019)

Biophysical Characterization of Met-G-CSF: Effects of Different Site-Specific Mono-Pegylations on Protein Stability and Aggregation
por: Natalello, Antonino, et al.
Publicado: (2012)

G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2019)

G-CSF-Associated Bone Marrow Necrosis in AML after Induction Chemotherapy
por: Osuorji, Ikenna, et al.
Publicado: (2012)

P1316: INCREASED EFFICACY OF INTERMEDIATE-DOSE ARAC+G-CSF COMPARED TO CY+G-CSF AND PLERIXAFOR+G-CSF AS A STEM CELL MOBILIZATION REGIMEN IN POOR MOBILIZERS WITH HEMATOLOGICAL MALIGNANCIES
por: Elkhova, Svetlana, et al.
Publicado: (2023)

Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats
por: Diederich, Kai, et al.
Publicado: (2014)

Regulation of the MAD1 promoter by G-CSF
por: Jiang, Kan, et al.
Publicado: (2008)

CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF
por: Srinivasan, T.N., et al.
Publicado: (1998)

Characterization of G-CSF receptor expression in medulloblastoma
por: Paul, Megan Rose, et al.
Publicado: (2020)

G-CSF Prevents Progression of Diabetic Nephropathy in Rat
por: So, Byung-Im, et al.
Publicado: (2013)

Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts
por: Zhao, Xiang-Yu, et al.
Publicado: (2015)

G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma
por: Zhang, Lingfu, et al.
Publicado: (2018)

Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis
por: Katano, Mitsuo, et al.
Publicado: (1995)

COVID-19 in a patient receiving adjuvant breast cancer chemotherapy with granulocyte olony-stimulating factor (G-CSF) support: A case report
por: Yerushalmi, Rinat, et al.
Publicado: (2021)

Establishment of the first international standard for PEGylated granulocyte colony stimulating factor (PEG-G-CSF): Report of an international collaborative study
por: Wadhwa, Meenu, et al.
Publicado: (2015)

A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patients.
por: de Wit, R., et al.
Publicado: (1998)

ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(−2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients
por: Watts, M J, et al.
Publicado: (2000)

A screen for peptide agonists of the G-CSF receptor
por: Conzelmann, Nadine, et al.
Publicado: (2011)

Presently available biosimilars in hematology-oncology: G-CSF
por: Gascon, Pere
Publicado: (2012)

Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans
por: Scholz, Markus, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2pgoiqcif979l1fcr13rvco2fc